NEXI (NexImmune Corp) Daromadning choraklik o'sishi (QoQ)

neximmune.com (NEXI) tovar belgisi

Sinf testlaridagi noaniqlik va mablag'lar yetishmasligi NexImmune, Inc. (NEXI) uchun jiddiy xavflarni yuzaga keltirdi. Choraklik daromadlar o'sishining qisqacha ko'rinishi ushbu pasayishni vizuallashtiradi, bunda 0.00 parametrning joriy holatini belgilaydi. O'ziga xos T-hujayralarni dasturlash tizimiga ega bo'lishiga qaramay, NexImmune, Inc. (NEXI) kapital yetishmasligi sababli tadqiqotlarni butunlay to'xtatgan va aktivlarini tugtatmoqda, bu esa kompaniyaning iqtisodiy ustunligini butunlay yo'q qildi.

NexImmune Corporation (NEXI) - O'tgan chorakka nisbatan daromad o'zgarishi 04.07.2022dan 04.08.2024gacha

NexImmune (NEXI) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:NEXI - NexImmune, Inc.
neximmune.com tomonidan chiqariladigan mahsulotlar

NexImmune, Inc. (NEXI) immunoterapiyasining samaradorligi borasidagi noaniqliklar biznesning yashovchanligini baholash uchun tijorat ijrosini monitoring qilishni muhim qiladi. Choraklik daromadlar o'sish sur'atlarini tahlil qilish orqali investorlar savdo dinamikasini real vaqt rejimida kuzatishlari mumkin, bu esa ularga fundamental muvaffaqiyatni bozor spekulyatsiyasidan ajratish va ushbu yuqori xavfli aktivlar sinfidagi institutsional kapitalning foydani realizatsiya qilishini o'z vaqtida aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

IBRX - Daromadning choraklik o'sishi (QoQ)|IMCR (immunocore.com) - Sotuvning choraklik o'sishi (QoQ)|Janux Corp (JANX) - Daromadning choraklik o'sishi (QoQ)|Choraklik daromad o'sish sur'ati Arcus Bio (RCUS)|Choraklik sotuv o'sishi ZYME|TNGX - O'tgan chorakka nisbatan daromad o'zgarishi|Choraklik sotuv o'sishi IOVA (Iovance)|Sotuvning choraklik o'zgarishi IMTX|Choraklik daromad o'sishi XNCR (Xencor)|Choraklik daromad ortishi CMPX|replimune.com - Choraklik daromad o'sishi|Choraklik daromad o'sish sur'ati Lyell Pharma|Innate Pharma S.A. (IPHA) - Daromadning choraklik o'sishi (QoQ)|Pyxis Oncology Inc. - Choraklik daromad ortishi|CGEN (Compugen Limited) - Choraklik daromad o'sishi|Choraklik daromad o'sishi IO Biotech Inc|Daromadning choraklik o'sishi (QoQ) Sutro Biopharma (STRO)|INKT: Daromadning choraklik dinamikasi|Werewolf Therapeutics, Inc. - Choraklik sotuv o'sishi|Immix (IMMX) - Choraklik daromad o'sish sur'ati|ALX Oncology Holdings Inc. - Choraklik daromad o'sishi|CUE - Choraklik daromad o'sishi|PDSB: Choraklik daromad o'sishi|Choraklik daromad o'sish sur'ati Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Choraklik daromad o'sishi|Choraklik sotuv o'sishi Liminatus Pharma (LIMN)|Choraklik daromad o'sishi LVTX|Sotuvning choraklik o'zgarishi NXTC|Leap Therapeutics, Inc. - Choraklik sotuv o'sishi|INTS: Sotuvning choraklik o'sishi (QoQ)|Sensei Biotherapeutics Inc - Choraklik daromad o'sishi|TOVX: Daromadning choraklik o'sishi (QoQ)|gritstonebio.com (GRTS) - Daromadning choraklik o'sishi (QoQ)|Sotuvning choraklik o'sishi (QoQ) KA|Daromadning choraklik o'sishi (QoQ) Turnstone Biologics Corp.|Sotuvning choraklik o'sishi (QoQ) VCNX (Vaccinex, Inc.)|Choraklik sotuv o'sishi HARP (Harpoon Tx)